Literature DB >> 26999470

Acute and chronic effects on central hemodynamics and arterial stiffness in professional rowers.

K Franzen1, M Reppel, J Köster, K Mortensen.   

Abstract

Controversial data exist on acute and chronic effects of competitive sports on central hemodynamics and arterial stiffness. We investigated chronic as well as acute training effects in professional rowers. The trial was planned as a non-randomized, controlled pilot-study comparing athletes and controls. 13 German national team rowers (24.1 ± 1.5 years) and 12 controls (23.8 ± 0.8 years) participated. Aortic, brachial hemodynamics and arterial stiffness were measured (Arteriograph, TensioMed(®), Hungary) before and after a standardized exercise test. Chronic heart rate (49 [Formula: see text] 2 bpm versus 70 [Formula: see text] 2 bpm, p  <  0.05) as well as brachial diastolic pressure (65 [Formula: see text] 2 mmHg versus 74 [Formula: see text] 2 mmHg, p  <  0.05) was significantly lower in rowers. Physical power (305 [Formula: see text] 63 versus 158 [Formula: see text] 60 W, p  <  0.001) was better. Chronic aortic pulse pressure (41.6 [Formula: see text] 6.0 versus 35.2 [Formula: see text] 3.8 mmHg; p  <  0.01) and AIx (9.1 [Formula: see text] 5.4 versus 7.0 [Formula: see text] 10.2; p  <  0.01) were significantly higher in athletes. After the all-out test (acute effects) pulse wave velocity (rowers: 6.6 [Formula: see text] 1.2 m s(-1) versus 7.8 [Formula: see text] 1.6 m s(-1), p  <  0.001; control group 6.0 [Formula: see text] 0.4 m s(-1) versus 8.0 [Formula: see text] 1.4 m s(-1), p  =  0.005) and heart rate (rowers: 49 [Formula: see text] 2 bpm versus 91 [Formula: see text] 3 bpm, p  <  0.001; control group 70 [Formula: see text] 2 bpm versus 92 [Formula: see text] 4 bpm, p  <  0.001) increased significantly in both groups. The controls' aortic AIx (7.0 [Formula: see text] 10.2 versus 2.0 [Formula: see text] 6.0; p  <  0.01) decreased significantly after exercise. Professional rowers showed higher chronic aortic pulse pressure and arterial stiffness. Given the risk associated with elevated aortic pulse pressure and AIx for development of cardiovascular diseases, longterm observations of professional rowers are needed with respect to arterial stiffness and prognosis. Furthermore the acute effects need additional research.

Entities:  

Mesh:

Year:  2016        PMID: 26999470     DOI: 10.1088/0967-3334/37/4/544

Source DB:  PubMed          Journal:  Physiol Meas        ISSN: 0967-3334            Impact factor:   2.833


  5 in total

1.  Elite athletes as research model: vitamin D insufficiency associates with elevated central blood pressure in professional handball athletes.

Authors:  Pascal Bauer; Lutz Kraushaar; Sophie Hölscher; Shahin Tajmiri-Gondai; Oliver Dörr; Holger Nef; Christian Hamm; Astrid Most
Journal:  Eur J Appl Physiol       Date:  2019-08-19       Impact factor: 3.078

2.  The impact of repetitive long-duration water immersion on vascular function.

Authors:  Erin E Simmons; Elizabeth R Bergeron; John P Florian
Journal:  PLoS One       Date:  2017-07-27       Impact factor: 3.240

3.  Carotid Arterial Stiffness and Hemodynamic Responses to Acute Cycling Intervention at Different Times during 12-Week Supervised Exercise Training Period.

Authors:  Hai-Bin Liu; Wen-Xue Yuan; Qing-Yong Wang; Yan-Xia Wang; Hou-Wen Cao; Jian Xu; Kai-Rong Qin
Journal:  Biomed Res Int       Date:  2018-07-16       Impact factor: 3.411

4.  Recovery Responses of Central Hemodynamics in Basketball Athletes and Controls After the Bruce Test.

Authors:  Yahui Zhang; Lin Qi; Frans van de Vosse; Chenglin Du; Yudong Yao; Jianhang Du; Guifu Wu; Lisheng Xu
Journal:  Front Physiol       Date:  2020-11-12       Impact factor: 4.566

5.  Differential Effects of Angiotensin-II Compared to Phenylephrine on Arterial Stiffness and Hemodynamics: A Placebo-Controlled Study in Healthy Humans.

Authors:  Klaas F Franzen; Moritz Meusel; Julia Engel; Tamara Röcker; Daniel Drömann; Friedhelm Sayk
Journal:  Cells       Date:  2021-05-05       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.